The number of genes within a panel may be as few as six (e.g. BAP1, FH, FLCN, MET, SDHB, and VHL genes) though commercial genetic testing companies may offer larger gene panels (18–30 genes but including some for non-RCC kidney tumours; (Supplementary Table 3)). This evidence concerns the gene MET and renal cell carcinoma.